Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

19.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.4K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

4.2K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.2K
Extraction: Advanced Methods00:56

Extraction: Advanced Methods

1.3K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.3K
Metal-Ligand Bonds02:51

Metal-Ligand Bonds

25.3K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
25.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.8K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Obstructive Sleep Apnea and Arrhythmia: A Narrative Review of Arrhythmogenic Mechanisms.

Diagnostics (Basel, Switzerland)·2026
Same author

Internal Teat Sealant as an Alternative to Intramammary Antibiotics at Dry-Off in Low-Risk Dairy Cows: Effects on Udder Health, Milk Yield, Antimicrobial Use, and Economic Outcomes.

Animals : an open access journal from MDPI·2026
Same author

The Maternal Microbiome in Pregnancy: From Physiological Changes to Dysbiosis and Obstetrical Complications-Therapeutic Perspectives.

Life (Basel, Switzerland)·2026
Same author

Skin Regeneration in Diabetic Rats Using Gold Nanoparticles-Bioactive Glass Oil-in-Water Cream.

Materials (Basel, Switzerland)·2026
Same author

Understanding Preeclampsia: Integrating Placental Dysfunction, Immune Dysregulation and microRNA-Mediated Epigenetic Regulation.

International journal of molecular sciences·2026
Same author

Synbiotics as a Microbiome-Based Strategy in Colorectal Cancer.

Nutrients·2026

相关实验视频

Updated: Mar 15, 2026

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

59.1K

铜复合物:作为抗癌剂的主要机制

Adriana Corina Hangan1, Luminița Simona Oprean1, Lucia Maria Procopciuc2

  • 1Department of Inorganic Chemistry, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Molecules (Basel, Switzerland)
|March 14, 2026
PubMed
概括
此摘要是机器生成的。

铜复合物在药物化学中至关重要,显示出作为抗瘤剂的前景. 本综述详细介绍了它们的作用机制,包括DNA相互作用和cuproptosis,用于开发新的癌症疗法.

关键词:
在DNA裂变的过程中,复杂的铜复合体中的铜.这就是cuproptosis.医学无机化学 医学无机化学蛋白酶体抑制剂 蛋白质酶体抑制剂毒性酶酶抑制剂的使用.

更多相关视频

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
11:04

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Published on: September 7, 2019

9.9K
Structure and Coordination Determination of Peptide-metal Complexes Using 1D and 2D 1H NMR
14:44

Structure and Coordination Determination of Peptide-metal Complexes Using 1D and 2D 1H NMR

Published on: December 16, 2013

10.1K

相关实验视频

Last Updated: Mar 15, 2026

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

59.1K
Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
11:04

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Published on: September 7, 2019

9.9K
Structure and Coordination Determination of Peptide-metal Complexes Using 1D and 2D 1H NMR
14:44

Structure and Coordination Determination of Peptide-metal Complexes Using 1D and 2D 1H NMR

Published on: December 16, 2013

10.1K

科学领域:

  • 药用化学 医学化学
  • 生物化学 生物化学
  • 毒理学 毒理学 毒理学

背景情况:

  • 铜对于生物氧化还原反应和代谢过程至关重要.
  • 铜复合物越来越多地研究其药用特性.
  • 类似于西斯的DNA-金属相互作用是铜复合体研究的主要焦点.

研究的目的:

  • 审查铜复合体在抗瘤活动中的作用机制.
  • 探索既有和新的途径,如反应性氧物种 (ROS) 生产和cuproptosis.
  • 为了突出人们对铜复合物在癌症治疗开发中的持续兴趣.

主要方法:

  • 对近几十年来铜复合体研究的文献综述.
  • 对研究铜复合物与生物点,特别是DNA的相互作用的研究进行分析.
  • 检查已记录的抗瘤机制,包括ROS生成和cuproptosis.

主要成果:

  • 铜复合体表现出不同的抗瘤机制.
  • 已确定的机制涉及DNA相互作用和ROS的产生.
  • 正在确定和研究像cuproptosis这样的新兴机制.

结论:

  • 铜复合物代表了癌症治疗的一类有前途的化合物.
  • 了解它们的多样化作用机制对于开发新型抗瘤剂至关重要.
  • 对铜复合机制的持续研究,包括铜,对于推进癌症治疗至关重要.